Caprock Group’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Sell
38,065
-2,110
-5% -$79.8K 0.03% 476
2026
Q1
$1.44M Sell
40,175
-57,620
-59% -$2.1M 0.03% 446
2025
Q4
$3.17M Sell
97,795
-13,465
-12% -$420K 0.07% 253
2025
Q3
$3.21M Buy
+111,260
New +$3.19M 0.08% 217
2025
Q1
$745K Buy
18,216
+1,349
+8% +$64.9K 0.02% 568
2024
Q4
$914K Buy
16,867
+8,645
+105% +$495K 0.03% 443
2024
Q3
$534K Buy
8,222
+2,442
+42% +$157K 0.02% 545
2024
Q2
$358K Buy
+5,780
New +$401K 0.01% 633

Other funds holding CRI

Caprock Group's CRI Position: Q2 2026 in Review

Caprock Group reduced its Carter's (CRI) stake by 5.3% in Q2 2026, selling an estimated $79.8K and leaving 38,065 shares worth $1.57M. The position accounts for 0.03% of the portfolio, ranked #476.

Caprock Group first reported a position in CRI in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.21M in Q3 2025. 288 funds tracked by Wall St. Rank hold CRI as of Q2 2026.

  • Caprock Group held 38,065 shares of Carter's worth $1.57M as of Q2 2026.
  • Caprock Group sold 2,110 Carter's shares in Q2 2026, an estimated $79.8K.
  • Carter's made up 0.03% of Caprock Group's portfolio in Q2 2026, its #476 holding.
  • Caprock Group first reported a position in Carter's in Q2 2024 and has held it in 8 quarters since.
  • Caprock Group's Carter's position peaked at $3.21M in Q3 2025.
  • 288 funds tracked by Wall St. Rank held Carter's as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.